e-Case Report
Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature
Tratamiento del síndrome de Sézary con alemtuzumab: serie de 5 casos y revisión de la literatura
Leído
7310
Vecesse ha leído el artículo
2523
Total PDF
4787
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 29 | 6 | 35 |
| 2025 5 | 193 | 37 | 230 |
| 2025 4 | 157 | 29 | 186 |
| 2025 3 | 134 | 53 | 187 |
| 2025 2 | 162 | 26 | 188 |
| 2025 1 | 96 | 28 | 124 |
| 2024 12 | 89 | 30 | 119 |
| 2024 11 | 113 | 65 | 178 |
| 2024 10 | 103 | 66 | 169 |
| 2024 9 | 109 | 38 | 147 |
| 2024 8 | 116 | 56 | 172 |
| 2024 7 | 80 | 32 | 112 |
| 2024 6 | 104 | 40 | 144 |
| 2024 5 | 71 | 33 | 104 |
| 2024 4 | 89 | 29 | 118 |
| 2024 3 | 82 | 43 | 125 |
| 2024 2 | 65 | 51 | 116 |
| 2024 1 | 83 | 48 | 131 |
| 2023 12 | 61 | 30 | 91 |
| 2023 11 | 60 | 29 | 89 |
| 2023 10 | 66 | 30 | 96 |
| 2023 9 | 72 | 47 | 119 |
| 2023 8 | 60 | 27 | 87 |
| 2023 7 | 72 | 39 | 111 |
| 2023 6 | 94 | 38 | 132 |
| 2023 5 | 55 | 40 | 95 |
| 2023 4 | 57 | 38 | 95 |
| 2023 3 | 64 | 47 | 111 |
| 2023 2 | 61 | 27 | 88 |
| 2022 1 | 51 | 27 | 78 |
| 2022 12 | 77 | 45 | 122 |
| 2022 11 | 44 | 35 | 79 |
| 2022 10 | 38 | 29 | 67 |
| 2022 9 | 31 | 41 | 72 |
| 2022 8 | 36 | 33 | 69 |
| 2022 7 | 41 | 42 | 83 |
| 2022 6 | 24 | 30 | 54 |
| 2022 5 | 57 | 37 | 94 |
| 2022 4 | 60 | 34 | 94 |
| 2022 3 | 50 | 48 | 98 |
| 2022 2 | 71 | 31 | 102 |
| 2021 1 | 41 | 31 | 72 |
| 2021 12 | 29 | 28 | 57 |
| 2021 11 | 46 | 41 | 87 |
| 2021 10 | 53 | 42 | 95 |
| 2021 9 | 55 | 37 | 92 |
| 2021 8 | 41 | 28 | 69 |
| 2021 7 | 40 | 31 | 71 |
| 2021 6 | 38 | 26 | 64 |
| 2021 5 | 46 | 37 | 83 |
| 2021 4 | 82 | 43 | 125 |
| 2021 3 | 69 | 21 | 90 |
| 2021 2 | 73 | 35 | 108 |
| 2020 1 | 37 | 32 | 69 |
| 2020 12 | 43 | 22 | 65 |
| 2020 11 | 24 | 23 | 47 |
| 2020 10 | 24 | 17 | 41 |
| 2020 9 | 45 | 15 | 60 |
| 2020 8 | 37 | 23 | 60 |
| 2020 7 | 47 | 18 | 65 |
| 2020 6 | 39 | 37 | 76 |
| 2020 5 | 30 | 20 | 50 |
| 2020 4 | 36 | 24 | 60 |
| 2020 3 | 50 | 27 | 77 |
| 2020 2 | 7 | 10 | 17 |
| 2020 1 | 4 | 1 | 5 |
| 2019 12 | 8 | 2 | 10 |
| 2019 11 | 4 | 5 | 9 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 5 | 7 | 12 |
| 2019 8 | 4 | 5 | 9 |
| 2019 7 | 8 | 8 | 16 |
| 2019 6 | 7 | 24 | 31 |
| 2019 5 | 4 | 14 | 18 |
| 2019 4 | 2 | 15 | 17 |
| 2019 3 | 0 | 4 | 4 |
| 2019 2 | 4 | 2 | 6 |
| 2019 1 | 2 | 2 | 4 |
| 2018 12 | 5 | 7 | 12 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 16 | 0 | 16 |
| 2018 9 | 5 | 0 | 5 |
| 2018 5 | 0 | 2 | 2 |
| 2018 4 | 0 | 2 | 2 |
| 2018 2 | 34 | 5 | 39 |
| 2018 1 | 29 | 4 | 33 |
| 2017 12 | 34 | 7 | 41 |
| 2017 11 | 31 | 3 | 34 |
| 2017 10 | 34 | 6 | 40 |
| 2017 9 | 17 | 3 | 20 |
| 2017 8 | 34 | 12 | 46 |
| 2017 7 | 22 | 13 | 35 |
| 2017 6 | 40 | 22 | 62 |
| 2017 5 | 33 | 6 | 39 |
| 2017 4 | 33 | 19 | 52 |
| 2017 3 | 12 | 16 | 28 |
| 2017 2 | 21 | 13 | 34 |
| 2016 1 | 21 | 11 | 32 |
| 2016 12 | 23 | 20 | 43 |
| 2016 11 | 29 | 17 | 46 |
| 2016 10 | 23 | 22 | 45 |
| 2016 8 | 0 | 1 | 1 |
| 2016 7 | 5 | 1 | 6 |
| 2016 6 | 11 | 2 | 13 |
| 2016 5 | 3 | 1 | 4 |
| 2016 4 | 3 | 1 | 4 |
| 2016 3 | 5 | 3 | 8 |
| 2016 2 | 0 | 1 | 1 |
| 2015 1 | 0 | 1 | 1 |
| 2015 12 | 0 | 2 | 2 |
| 2015 11 | 0 | 2 | 2 |
| 2015 10 | 0 | 4 | 4 |
Mostrar todo
